Table 1. Patients’ Characteristic Between Two Groups.
| Variable | Promethazine Group n = 40 | Metoclopramid Group (n = 40) | P Value |
|---|---|---|---|
| Age, y | 34.41 ± 12.05 | 33.58 ± 13.37 | 0.4 |
| Gender (F/M) | 33/7 | 34/6 | 0.1 |
| BMI, kg/m 2 | 40.87 ± 3.38 | 40.67 ± 3.68 | 0.3 |
| FBS, mg/dL | 100.23 ± 19.54 | 102.05 ± 21.91 | 0.1 |
| Triglyceride, mg/dL | 187.38 ± 39.59 | 197.95 ± 58.85 | 0.02 |
| Cholesterol, mg/dL | 201.51 ± 38.84 | 229.20 ± 50.82 | 0.01 |
| MAP, mmgh | 82.4 ± 5.2 | 84.6 ± 3.4 | 0.2 |
| Sleep apnea, n | 3 | 3 | 1 |
| Total pethedine Use, mg | 32.1 ± 2.6 | 68.5 ± 4.6 | 0.00 |
Abbreviations: BMI, body mass index; MAP, mean arterial pressure.